ArticleArchives of rheumatology2025

Real-World Outcomes of Baricitinib Monotherapy Versus csDMARD Combination Therapy in Rheumatoid Arthritis: A SingleCenter Retrospective Analysis of Efficacy, Safety, and Drug Retention.

Mete Kara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.